Simple, effective interventions are key to improving adherence in marginalized populations

Clinical Infectious Diseases

Volumn 45, Issue 7, 2007, Pages 916-917

  Mills, Edward J ^a   Cooper, Curtis ^b  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE DELIVERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION SYSTEM; NOTE; PATIENT COMPLIANCE; PATIENT COUNSELING; PILLBOX ORGANIZER; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS LOAD; COHORT ANALYSIS; DIRECTLY OBSERVED THERAPY; DRUG SELF ADMINISTRATION; FEMALE; HOMELESSNESS; HOSPITAL ORGANIZATION; MALE; METHODOLOGY;

ANTI-RETROVIRAL AGENTS; COHORT STUDIES; DIRECTLY OBSERVED THERAPY; FEMALE; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; MALE; MEDICATION SYSTEMS; PATIENT COMPLIANCE; SELF ADMINISTRATION;

EID: 34848859861     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/521249     Document Type: Note

References (9)

1. Petersen ML, Wang Y, van der Laan MJ, et al. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis 2007; 45:908-15 (in this issue).
2. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002; 288:2868-79.
3. Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006; 3:e438.
4. Conner J, Rafter N, Rogers A. Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Org 2004; 82:935-9.
5. Wohl AR, Garland WH, Valencia R. A randomized trial of directly administered antiretroviral therapy and adherence care management intervention. Clin Infect Dis 2006; 42:1619-27.
6. Kerr T, Walsh J, Lloyd-Smith E, Wood E. Measuring adherence to highly active antiretroviral therapy: implications for research and practice. Curr HIV/AIDS Rep 2005; 2:200-5.
7. Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis 2005; 191:339-47.
8. Bangsberg D, Acosta E, Gupta R, et al. Adherence-resistance relationships for protease inhibitors and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS 2006; 20:223-31.
9. Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med 1984; 3:409-22.